Amgen Financials
| AMGN Stock | MXN 4,651 201.54 4.53% |
Amgen |
Understanding current and past Amgen Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Amgen's financial statements are interrelated, with each one affecting the others. For example, an increase in Amgen's assets may result in an increase in income on the income statement.
The data published in Amgen's official financial statements usually reflect Amgen's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Amgen Inc. For example, before you start analyzing numbers published by Amgen accountants, it's critical to develop an understanding of what Amgen's liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Amgen's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Amgen's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Amgen's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Amgen Inc. Please utilize our Beneish M Score to check the likelihood of Amgen's management manipulating its earnings.
Amgen Stock Summary
Amgen competes with Eli Lilly, Roche Holding, Bristol Myers, Sanofi, and Biogen. Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California. AMGEN INC operates under Drug Manufacturers - Major classification in Mexico and is traded on Mexico Stock Exchange. It employs 21500 people.| Foreign Associate | USA |
| Instrument | Mexico Stock View All |
| Exchange | Mexican Exchange |
| Business Address | One Amgen Center |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Major |
| Benchmark | NYSE Composite |
| Website | www.amgen.com |
| Phone | 805 447 1000 |
| Currency | MXN - Mexican Peso |
You should never invest in Amgen without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Amgen Stock, because this is throwing your money away. Analyzing the key information contained in Amgen's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Amgen Key Financial Ratios
Generally speaking, Amgen's financial ratios allow both analysts and investors to convert raw data from Amgen's financial statements into concise, actionable information that can be used to evaluate the performance of Amgen over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Amgen Inc reports annually and quarterly.| Return On Equity | 1.26 | |||
| Return On Asset | 0.0997 | |||
| Beta | 0.63 |
Amgen Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Amgen's current stock value. Our valuation model uses many indicators to compare Amgen value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Amgen competition to find correlations between indicators driving Amgen's intrinsic value. More Info.Amgen Inc is rated second in return on equity category among related companies. It is rated fourth in return on asset category among related companies reporting about 0.08 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Amgen Inc is roughly 12.69 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Amgen by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Amgen's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Amgen's earnings, one of the primary drivers of an investment's value.Amgen Inc Systematic Risk
Amgen's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Amgen volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on Amgen Inc correlated with the market. If Beta is less than 0 Amgen generally moves in the opposite direction as compared to the market. If Amgen Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Amgen Inc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Amgen is generally in the same direction as the market. If Beta > 1 Amgen moves generally in the same direction as, but more than the movement of the benchmark.
About Amgen Financials
What exactly are Amgen Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Amgen's income statement, its balance sheet, and the statement of cash flows. Potential Amgen investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Amgen investors may use each financial statement separately, they are all related. The changes in Amgen's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Amgen's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Steps to analyze Amgen Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Amgen is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Amgen has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Amgen's financials are consistent with your investment objective using the following steps:- Review Amgen's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand Amgen's liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare Amgen's financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Amgen's stock is overvalued or undervalued.
Amgen April 25, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Amgen help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Amgen Inc. We use our internally-developed statistical techniques to arrive at the intrinsic value of Amgen Inc based on widely used predictive technical indicators. In general, we focus on analyzing Amgen Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Amgen's daily price indicators and compare them against related drivers.
| Information Ratio | (0.08) | |||
| Maximum Drawdown | 19.19 | |||
| Value At Risk | (1.34) | |||
| Potential Upside | 2.27 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amgen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Complementary Tools for Amgen Stock analysis
When running Amgen's price analysis, check to measure Amgen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amgen is operating at the current time. Most of Amgen's value examination focuses on studying past and present price action to predict the probability of Amgen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amgen's price. Additionally, you may evaluate how the addition of Amgen to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |